RxDoctor Payments Data

Matthew Bassan

Sports Medicine · Wayne, NJNPI 1881019594

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (39.1%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by IBSA Pharma Inc. at 44.6% of the total. Reporting peaked in 2019 at $4,535 and has fallen 97.7% since, to $103 in 2025.

$8,961in general payments, 2019–2025

Across 93 payments — averaging $96.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • IBSA Pharma Inc.$4K
  • Fidia Pharma USA Inc.$4K
  • Novo Nordisk$278
  • Johnson & Johnson$224
  • Amgen$174
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$104
  • plus $521 from 14 others

What the payments were for

  • Consulting fees$3,50039%
  • Speaking & faculty fees$3,37538%
  • Travel & lodging$7869%
  • Food & beverage$1,30015%

General payments by program year

19
20
21
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,961 in reported general payments places this provider in the 80th percentile of 221 sports medicine providers in New Jersey.

See all sports medicine providers in New Jersey

Other sports medicine in Wayne

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →